EMPAGLIMET 12.5/850MG TAB

EMPAGLIMET 12.5/850MG TAB is a combination medication containing empagliflozin and metformin. This dual-action formula helps manage type 2 diabetes by improving blood sugar control through two mechanisms: metformin reduces glucose production in the liver, while empagliflozin helps the kidneys eliminate excess sugar through urine. Suitable for patients requiring enhanced glycemic control, EMPAGLIMET offers convenient once-daily dosing with proven efficacy in reducing HbA1c levels. The combination therapy may also provide cardiovascular and renal protective benefits. Always use as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.